CSAT's QT interval screening in methadone report: Outrageous fortune or sea of troubles?

Journal of Addictive Diseases

Volumn 30, Issue 4, 2011, Pages 313-317

  Bart, Gavin ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ARTICLE; HEART DEATH; HUMAN; MAINTENANCE THERAPY; METHADONE TREATMENT; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

HUMANS; LONG QT SYNDROME; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT SAFETY; TORSADES DE POINTES; UNITED STATES; UNITED STATES SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION;

EID: 84855792915     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.610707     Document Type: Article

References (25)

1. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008; 300:1423-31.
2. Goldberg RJ, Bengtson J, Chen ZY, Anderson KM, Locati E, Levy D. Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). AmJ Cardiol 1991; 67:55-8.
3. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19:1391-400. (Pubitemid 28427142)
4. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med 2004; 164:943-8. (Pubitemid 38581512)
5. Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol 2008; 51:2291-300. (Pubitemid 351783362)
6. Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J 1973; 86:663-8.
7. Greene MH, Luke JL, DuPont RL. Acute opiate overdose: a preliminary report on mechanisms of death. Proc Natl Conf Methadone Treat 1973; 1:330-5.
8. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation duringmethadone and buprenorphine treatment: a mortality assessment study. Addiction 2009; 104:993-9.
9. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58:1161-7. (Pubitemid 33121508)
10. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6. (Pubitemid 351632017)
11. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med 2009; 150:199-205.
12. Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-gogo related geneK(+) currents. J Pharmacol Exp Ther 2002; 303:688-94. (Pubitemid 35231242)
13. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005; 14:747-53. (Pubitemid 41684467)
14. Fishman GI, Chugh SS, Dimarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010; 122:2335-48.
15. Bart G, Bart BA, Karim R, Wyman Z. Methadone dose and the QTc interval: little clinical relevance big unknowns. Abstract from the Seventy-ThirdAnnual Scientific Meeting; College on Problems of Drug Dependence, Hollywood, Florida, 2011.
16. Anchersen K, Hansteen V, Gossop M, Clausen T, Waal H. Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor. Drug Alcohol Depend 2010; 112:216-9.
17. Ehret GB, Voide C, Gex-Fabry M, et al. Druginduced longQTsyndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med 2006; 166:1280-7. (Pubitemid 43967579)
18. Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007; 93:1051-5. (Pubitemid 47310981)
19. Maremmani I, Pacini M, Cesaroni C, Lovrecic M, Perugi G, Tagliamonte A. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 2005; 11:44-9. (Pubitemid 40082210)
20. Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction 2007; 102:289-300. (Pubitemid 46096291)
21. Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 2005; 95:915-8. (Pubitemid 40386816)
22. Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, lev- omethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007; 167:2469-75. (Pubitemid 350254906)
23. Ansermot N, Albayrak O, Schlapfer J, et al. Substitution of (R,S)-methadone by (R)-methadone: impact on QTc interval. Arch Intern Med 2010; 170: 529-36.
24. Eap CB, Crettol S, Rougier JS, et al. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther 2007; 81:719-28. (Pubitemid 46625109)
25. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008; 118: 1497-518.